Evidence map›Paper›PMID 42851787›Full record

ArticleRSC chemical biology2026

Exploring RiPP-derived

Nina M Bösch, Manon Coste, Johannes A Rudmann Eckert, Gabriel Cervera Arriaga, Annina R Meyer, Eléonore Moore, Daniel Richter, Jörn Piel, Anna L Vagstad

Abstract read
In one paragraph

Article in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nina M BöschInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0000-0001-6656-7040
Manon CosteInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0009-0008-3881-7856
Johannes A Rudmann EckertInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0000-0002-5398-0562
Gabriel Cervera ArriagaInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0009-0002-0415-5299
Annina R MeyerInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0009-0006-3110-6598
Eléonore MooreInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0009-0009-8359-6447
Daniel RichterInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0000-0003-2583-520X
Jörn PielInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0000-0002-2282-8154
Anna L VagstadInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Vladimir-Prelog-Weg 4 8093 Zürich Switzerland avagstad@ethz.ch.ORCID https://orcid.org/0000-0001-8074-0137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopeptides possess diverse bioactivities with widespread uses as antimicrobial drugs and biosurfactants but their biosynthetic engineering remains challenging. Classical lipopeptides (such as daptomycin or surfactin) are biosynthesized by modular, non-ribosomal megasynthetases. An alternative streamlined route to lipopeptides are the ribosomally synthesized and post-translationally modified peptides (RiPPs) derived from gene-encoded precursor proteins. We recently characterized a novel class of post-translational modification enzymes in RiPPs that catalyze fatty acylation of ornithine and lysine side chains. The resulting lipopeptides were termed selidamides. To assess the use of selidamide

Identifiers

PMID42851787
PMCPMC13647313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.